DEF 14A

Company

PDS Biotechnology Corp

Filed

August 16, 2019

Period of Report

September 24, 2019

Accession Number

0001140361-19-015162

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →